Jupiter Bioscience in negotiation for Rs 75 cr contract; stock up
Shares of Jupiter Bioscience moved higher after the company announced that it is in negotiation with European multinational pharmaceutical companies for a multi year supply contract worth Rs 75 crores for peptide building blocks.
By ET Bureau |
MUMBAI: Shares of Jupiter Bioscience moved higher after the company announced that it is in negotiation with European multinational pharmaceutical companies for a multi year supply contract worth Rs 75 crores for peptide building blocks.
The company also plans to raise upto $100 million through preferential issue, QIP, FCCB'S, ADRs, GDRs, etc for funding various business projects including acquisitions in India and overseas.
The stock was at Rs 52.60, up 1.45 per cent on the BSE. It touched a high of Rs 53 and low of Rs 51.55 in trade so far.
The company also plans to raise upto $100 million through preferential issue, QIP, FCCB'S, ADRs, GDRs, etc for funding various business projects including acquisitions in India and overseas.
The stock was at Rs 52.60, up 1.45 per cent on the BSE. It touched a high of Rs 53 and low of Rs 51.55 in trade so far.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
